Abstract
A series of 142 patients with Hodgkin's disease of the nodular sclerosis and mixed histologic types who received chemotherapy is presented. Seventy-six of the patients had received radiotherapy before chemotherapy. The median survival after institution of chemotherapy was 20 months. Regardless of sex or histologic type, die 10-29 age group significantly outlived the 60+ age group. The nodular sclerosis histologic type was superior to the mixed type only within the 30-59 age group. Within any particular age-histology subgroup, the females did not significantly outlive the males. Overall, however, the females tended to be younger than the males and to have more nodular sclerosis, both of which conferred an advantage. The data also suggest that chemotherapy in Hodgkin's disease may prolong life.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
